Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
dc.contributor.author | Haselmann, Verena | |
dc.contributor.author | Özçürümez, Mustafa K | |
dc.contributor.author | Klawonn, Frank | |
dc.contributor.author | Ast, Volker | |
dc.contributor.author | Gerhards, Catharina | |
dc.contributor.author | Eichner, Romy | |
dc.contributor.author | Costina, Victor | |
dc.contributor.author | Dobler, Gerhard | |
dc.contributor.author | Geilenkeuser, Wolf-Jochen | |
dc.contributor.author | Wölfel, Roman | |
dc.contributor.author | Neumaier, Michael | |
dc.date.accessioned | 2020-09-10T09:39:51Z | |
dc.date.available | 2020-09-10T09:39:51Z | |
dc.date.issued | 2020-08-27 | |
dc.identifier.citation | Clin Chem Lab Med. 2020;/j/cclm.ahead-of-print/cclm-2020-1183/cclm-2020-1183.xml. doi:10.1515/cclm-2020-1183. | en_US |
dc.identifier.pmid | 32853163 | |
dc.identifier.doi | 10.1515/cclm-2020-1183 | |
dc.identifier.uri | http://hdl.handle.net/10033/622437 | |
dc.language.iso | en | en_US |
dc.publisher | DeGruyter | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.subject | COVID-19 | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | external quality assessment scheme | en_US |
dc.subject | proficiency testing | en_US |
dc.subject | ring trial | en_US |
dc.title | Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing. | en_US |
dc.type | Article | en_US |
dc.identifier.eissn | 1437-4331 | |
dc.contributor.department | HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany. | en_US |
dc.identifier.journal | Clinical chemistry and laboratory medicine | en_US |
dc.source.journaltitle | Clinical chemistry and laboratory medicine | |
dc.source.country | Germany |